Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
NCT ID: NCT07110935
Last Updated: 2025-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
290 participants
INTERVENTIONAL
2018-09-13
2019-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However,parenteral iron treatment is expected to be advantageous in cases where oral iron therapy is not possible.As a result,there is increased interest in parenteral iron therapy.
Objectives:To determine the effect of treatment of postpartum anaemia with intravenous versus oral iron therapy at Federal Medical Centre,Umuahia.
Materials and Method:This study is a prospective randomized controlled study carried out in department of Obstetric and Gynaecology, Federal Medical Centre,Umuahia,the capital of Abia State,South-east, Nigeria. The study population comprised of postpartum women with mild to moderate anaemia within 48 hours of delivery who were randomized into two groups.One group will be given oral iron therapy and the other intravenous iron dextran.Response and comparative effects of treatment using either route of administration were assessed at 6 weeks postpartum.The biodata,obstetric characteristics and haemoglobin estimation of the respondents were recorded on a structured study proforma.The data obtained from the study was analyzed with the statistical package for the social sciences(SPSS) software.Continuous variables obtained from this study were expressed as mean and standard deviation while categorical variables were summarized using frequency and percentages.Association between categorical variables were done using chi square.P-value less than 0.05 was taken as significant.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia
NCT07340450
Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia
NCT00660933
Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia
NCT05047211
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
NCT03957057
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
One hundred and forty five women who picked "i" were assigned intravenous iron therapy group
intravenous iron
intravenous iron dextran
One hundred and forty five women who picked "o" were assigned oral iron therapy group
oral iron
oral iron(ferrous Sulphate)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intravenous iron
intravenous iron dextran
oral iron
oral iron(ferrous Sulphate)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women with mild and moderate anaemia
* Women who gave their consent to participate in the study.
Exclusion Criteria
* Women with multiple pregnancy
* Women with genotype HbSS
* Women with HIV infection
* Women who delivered by caesarean section
* Women with co-morbidity like hypertensive disorders, renal pathology
* Women who decline consent after adequate counseling.
* Previous and current history of adverse reaction to iron dextran
20 Years
39 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal Teaching Hospital Abakaliki
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assumpta Nnenna Nweke
Dr Assumpta Nnenna Nweke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal Medical Centre , Umuahia
Umuahia, Abia State, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMC/QEH/G.596/Vol.10/266
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.